Pancreatic Cancer Research

ResearcherRajiv Gandhi Cancer Institute and Research CentreActive in the last 2 years

Shivendra Singh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8520-9545; OpenAlex author ID A5080495127. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

  1. Comparative Efficacy and Toxicity of Modified FOLFIRINOX and Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma: A Real-World Retrosp… Last author DOI 10.7759/cureus.87389↗
  2. Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) - Results from the Multicentre Indian Pancreatic & Periampull… Co-author DOI 10.1007/s12029-023-00936-1↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Arpit Jain · 1 shared paper, 2025 · strength 0.26
  2. Vikram Anil Chaudhari · 1 shared paper, 2023 · strength 0.12
  3. Vikas S. Ostwal · 1 shared paper, 2023 · strength 0.12
  4. Manish Suresh BHANDARE · 1 shared paper, 2023 · strength 0.12
  5. Shailesh Vinayak Shrikhande · 1 shared paper, 2023 · strength 0.12
  6. Anant Ramaswamy · 1 shared paper, 2023 · strength 0.12
  7. Vaibhav Kumar Varshney · 1 shared paper, 2023 · strength 0.12
  8. Adarsh Chaudhary · 1 shared paper, 2023 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.